NINL expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
<1E-12 |
Normal-vs-Stage2 |
1.62447832963153E-12 |
Normal-vs-Stage3 |
1.62436730732907E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
4.544000E-01 |
Stage1-vs-Stage3 |
5.857700E-02 |
Stage1-vs-Stage4 |
4.846200E-01 |
Stage2-vs-Stage3 |
4.970800E-01 |
Stage2-vs-Stage4 |
9.911000E-01 |
Stage3-vs-Stage4 |
5.113600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
1.36879999557138E-08 |
Normal-vs-Asian |
7.76210000000832E-05 |
Caucasian-vs-AfricanAmerican |
3.027300E-04 |
Caucasian-vs-Asian |
6.398000E-01 |
AfricanAmerican-vs-Asian |
3.786600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11022302462516E-16 |
Normal-vs-Female |
1.62436730732907E-12 |
Male-vs-Female |
1.363110E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.94120283683696E-12 |
Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
1.4432899320127E-15 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.462400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.360800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.851200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.149600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.318600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.772000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.93709999999948E-05 |
Normal-vs-Grade 2 |
<1E-12 |
Normal-vs-Grade 3 |
1.62436730732907E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
1.921190E-01 |
Grade 1-vs-Grade 3 |
3.133800E-01 |
Grade 1-vs-Grade 4 |
1.255180E-01 |
Grade 2-vs-Grade 3 |
1.250600E-01 |
Grade 2-vs-Grade 4 |
2.773000E-01 |
Grade 3-vs-Grade 4 |
2.244200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62447832963153E-12 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
4.328200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
<1E-12 |
Normal-vs-N1 |
1.10667031094636E-12 |
N0-vs-N1 |
5.579400E-01 |
|
|